Sunshine Biopharma Inc (SBFM) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Sunshine Biopharma Inc   (NASDAQ: SBFM)
 

Sunshine Biopharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Sunshine Biopharma Inc inventory turnover ratio, the Sunshine Biopharma Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.87 in the second quarter 2026, yet the ratio remained below the average, as SBFM's market remain challenging.Average inventory processing period, for the Sunshine Biopharma Inc in Jun 30 2026 quarter, has decreased to 195 days, compare to 206 days, in the Mar 31 2026 quarter.

Within Healthcare sector 219 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1626, from total ranking in the first quarter 2026 at 1815.

SBFM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sunshine Biopharma Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SBFM Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -6.89 % 11.06 % 19.45 % 43.2 % 53.33 %
Y / Y Cost of Sales Growth 14.19 % -4.26 % -14.67 % 13.91 % -13.81 %
Inventory Turnover Ratio (TTM) 1.87 1.77 1.84 1.99 2.11
SBFM's Total Ranking # 1626 # 1815 # 1589 # 1549 # 1438
Average inventory processing period 196 206 199 183 173
Seq. Inventory Growth -7.95 % -2.25 % -4.21 % 8.03 % 9.8 %
Seq. Cost of Sales Growth 15.73 % 6.48 % -12.54 % 5.95 % -2.97 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 62
Healthcare Sector # 220
Overall Market # 1626

Inventory Turnover Ratio Statistics
High Average Low
3.46 2.08 0.68
(Dec 31 2023)   (Dec 31 2019)



SBFM Company Profile >> Back to SBFM Efficiency Comparisons >> Compare SBFM Inventory Turnover Ratio to its Competitors

Financial Statements
Sunshine Biopharma Inc 's Inventories $ 12 Millions Visit SBFM's Balance sheet
Sunshine Biopharma Inc 's Cost of Revenues TTM $ 25 Millions Visit SBFM's Income Statement
What are SBFM's Sales? Visit SBFM's Sales by Segment

Other Inventory Turnover Ratios
Sunshine Biopharma Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SBFM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SBFM's Competitors
Inventory Turnover Ratio for SBFM's Suppliers
Inventory Turnover Ratio for SBFM's Customers

You may also want to know
SBFM's Sales Growth Rates SBFM's Pe Price to earnings ratio SBFM's Receivables Turnover Ratio SBFM's Stock Quote
SBFM's Net Income Growth Rates SBFM's Ps Price to Sales ratio SBFM's Sales per Employee SBFM's Asset Turnover Ratio
SBFM's Net Margin SBFM's Pb Price to Book ratio SBFM's Financial Strength Ratios SBFM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions

Date modified: 2026-09-02T20:05:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.